• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血脑屏障与脑肿瘤的化疗治疗

Blood-brain barrier and chemotherapeutic treatment of brain tumors.

作者信息

de Vries Nienke A, Beijnen Jos H, Boogerd Willem, van Tellingen Olaf

机构信息

The Netherlands Cancer Institute, Department of Clinical Chemistry, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

出版信息

Expert Rev Neurother. 2006 Aug;6(8):1199-209. doi: 10.1586/14737175.6.8.1199.

DOI:10.1586/14737175.6.8.1199
PMID:16893347
Abstract

The blood-brain barrier (BBB) is of pivotal importance to maintain homeostasis of the CNS, as it closely regulates the composition of the interstitial fluid in the brain. Unfortunately, malignancies that grow within the CNS may evade chemotherapeutic drugs using the same barrier, making this disease refractory to most chemotherapy regimens. This review will outline the impact of the BBB in brain cancer and discuss the efforts that have been made to enhance the drug exposure of brain tumors. Although this review will focus on the role of the BBB in primary brain cancer (malignant glioma), its impact on brain metastases will also be briefly discussed.

摘要

血脑屏障(BBB)对于维持中枢神经系统(CNS)的内环境稳定至关重要,因为它密切调节脑间质液的成分。不幸的是,中枢神经系统内生长的恶性肿瘤可能利用同一屏障逃避化疗药物,使得这种疾病对大多数化疗方案具有难治性。本综述将概述血脑屏障在脑癌中的影响,并讨论为提高脑肿瘤药物暴露量所做的努力。尽管本综述将重点关注血脑屏障在原发性脑癌(恶性胶质瘤)中的作用,但也将简要讨论其对脑转移瘤的影响。

相似文献

1
Blood-brain barrier and chemotherapeutic treatment of brain tumors.血脑屏障与脑肿瘤的化疗治疗
Expert Rev Neurother. 2006 Aug;6(8):1199-209. doi: 10.1586/14737175.6.8.1199.
2
Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review).放疗引起的血脑屏障通透性变化:对化疗时机的影响?(综述)
Oncol Rep. 2002 Jul-Aug;9(4):683-8.
3
Chemotherapy delivery issues in central nervous system malignancy: a reality check.中枢神经系统恶性肿瘤的化疗给药问题:现实审视
J Clin Oncol. 2007 Jun 1;25(16):2295-305. doi: 10.1200/JCO.2006.09.9861.
4
Chemotherapy and the treatment of brain metastases.化疗与脑转移瘤的治疗
Hematol Oncol Clin North Am. 2006 Dec;20(6):1287-95. doi: 10.1016/j.hoc.2006.09.007.
5
[The blood-brain barrier: implications for chemotherapy in brain tumors].[血脑屏障:对脑肿瘤化疗的影响]
Pathol Biol (Paris). 1991 Oct;39(8):789-95.
6
The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?抗癌药物通过血脑屏障的靶向递送:药物还是药物纳米颗粒的化学修饰?
Drug Discov Today. 2008 Dec;13(23-24):1099-106. doi: 10.1016/j.drudis.2008.09.005. Epub 2008 Oct 22.
7
The blood-brain barrier and cancer: transporters, treatment, and Trojan horses.血脑屏障与癌症:转运体、治疗方法及特洛伊木马策略
Clin Cancer Res. 2007 Mar 15;13(6):1663-74. doi: 10.1158/1078-0432.CCR-06-2854.
8
Drug delivery to brain tumours: challenges and progress.药物递送至脑肿瘤:挑战与进展。
Expert Opin Drug Deliv. 2006 Jul;3(4):499-509. doi: 10.1517/17425247.3.4.499.
9
Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors.恶性脑肿瘤化疗中血脑屏障的改变
Fed Proc. 1984 Feb;43(2):214-9.
10
Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?肿瘤学中血脑屏障的调节:治疗脑肿瘤的治疗机会?
Cancer Treat Rev. 2004 Aug;30(5):415-23. doi: 10.1016/j.ctrv.2004.04.001.

引用本文的文献

1
Targeting the undruggable in glioblastoma using nano-based intracellular drug delivery.利用基于纳米的细胞内药物递送靶向治疗胶质母细胞瘤中的不可成药靶点。
Med Oncol. 2024 Oct 29;41(12):303. doi: 10.1007/s12032-024-02546-8.
2
Second-line monotherapy with a PD-1/CTLA-4 inhibitor effectively treated multiple brain and lung metastases of cervical cancer: a case report.二线单药 PD-1/CTLA-4 抑制剂治疗有效宫颈癌多发脑肺转移 1 例报告。
Front Immunol. 2024 Oct 14;15:1434697. doi: 10.3389/fimmu.2024.1434697. eCollection 2024.
3
Meta-analysis of the make-up and properties of in vitro models of the healthy and diseased blood-brain barrier.
健康和患病血脑屏障体外模型的组成与特性的荟萃分析。
Nat Biomed Eng. 2025 Apr;9(4):566-598. doi: 10.1038/s41551-024-01250-2. Epub 2024 Sep 20.
4
SPDYC serves as a prognostic biomarker related to lipid metabolism and the immune microenvironment in breast cancer.SPDYC 可作为与乳腺癌脂质代谢和免疫微环境相关的预后生物标志物。
Immunol Res. 2024 Oct;72(5):1030-1050. doi: 10.1007/s12026-024-09505-5. Epub 2024 Jun 18.
5
Antibiotics treatment promotes vasculogenesis in the brain of glioma-bearing mice.抗生素治疗促进荷瘤小鼠大脑中的血管生成。
Cell Death Dis. 2024 Mar 13;15(3):210. doi: 10.1038/s41419-024-06578-w.
6
The Glioblastoma Landscape: Hallmarks of Disease, Therapeutic Resistance, and Treatment Opportunities.胶质母细胞瘤全景:疾病特征、治疗抗性与治疗机遇
Med Res Arch. 2023 Jun 30;11(6). doi: 10.18103/mra.v11i6.3994. Epub 2023 Jun 26.
7
Targeting diffuse midline gliomas: The promise of focused ultrasound-mediated blood-brain barrier opening.靶向弥漫性中线胶质瘤:聚焦超声介导的血脑屏障开放的前景。
J Control Release. 2024 Jan;365:412-421. doi: 10.1016/j.jconrel.2023.11.037. Epub 2023 Nov 30.
8
MRI-guided focused ultrasound blood-brain barrier opening increases drug delivery and efficacy in a diffuse midline glioma mouse model.磁共振成像引导的聚焦超声打开血脑屏障可提高弥漫性中线胶质瘤小鼠模型中的药物递送和疗效。
Neurooncol Adv. 2023 Sep 12;5(1):vdad111. doi: 10.1093/noajnl/vdad111. eCollection 2023 Jan-Dec.
9
Reactive oxidative species (ROS)-based nanomedicine for BBB crossing and glioma treatment: current status and future directions.基于活性氧(ROS)的纳米医学用于血脑屏障穿透和脑胶质瘤治疗:现状与未来方向。
Front Immunol. 2023 Sep 4;14:1241791. doi: 10.3389/fimmu.2023.1241791. eCollection 2023.
10
Transcranial histotripsy parameter study in primary and metastatic murine brain tumor models.原发性和转移性脑肿瘤模型中转颅组织爆破参数研究。
Int J Hyperthermia. 2023;40(1):2237218. doi: 10.1080/02656736.2023.2237218.